POWERHOUSE AESTHETIC BRANDS ALIGN TO LAUNCH A NATIONWIDE PREVENTATIVE SKIN HEALTH PROTOCOL EXPERIENCE
02 mai 2022 08h45 HE
|
Colorescience
Phoenix, AZ, May 02, 2022 (GLOBE NEWSWIRE) -- Know Better Skin this Summer with Colorescience®, a leader in advanced skin protection technology, and Aesthetics Biomedical®, a leader in novel...
Qualigen Therapeutics Resumes Worldwide Distribution and Commercial Control Over FastPack®
05 avr. 2022 09h15 HE
|
Qualigen Therapeutics, Inc.
Company Prepared for Growth and Improved Profitability of its Diagnostics Business CARLSBAD, Calif., April 05, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified...
RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
24 janv. 2022 07h00 HE
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Jan. 24, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
Invectys to Provide 2022 Business Outlook at the H.C. Wainwright Bioconnect Virtual Conference
06 janv. 2022 09h00 HE
|
Invectys, Inc.
Houston, Texas, USA, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Invectys Inc. will participate in the H.C. Wainwright Bioconnect Virtual Conference January 10-13, 2022. Praveen Tyle, Ph.D., Invectys Inc....
RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
29 nov. 2021 08h45 HE
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J.,, Nov. 29, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
Triple Hair Group renforce son conseil d'administration par l'ajout de compétences dans le domaine des marchés financiers et des sciences de la vie
29 nov. 2021 08h00 HE
|
Triple Hair Inc.
MONTRÉAL, 29 nov. 2021 (GLOBE NEWSWIRE) -- Triple Hair Group Inc. (« Triple Hair » ou la « Société »), une société spécialisée dans le développement de traitements novateurs pour lutter contre...
Triple Hair Group adds further capital markets and life science expertise to board
29 nov. 2021 08h00 HE
|
Triple Hair Inc.
MONTREAL, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Triple Hair Group Inc. (“Triple Hair” or the “Company”), a company specializing in the development of innovative treatments for alopecia, is pleased to...
RespireRx Pharmaceuticals Inc. Announces CEO’s OTC Venture Market Podcast
22 nov. 2021 08h45 HE
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI), (“RespireRx” or the “Company”) a leader in the discovery and development of innovative and...
CURATIVE BIOTECHNOLOGY ANNOUNCES DR. CATHERINE SOHN AS SPECIAL ADVISOR TO BOARD AND CEO
12 oct. 2021 10h12 HE
|
Curative Biotechnology, Inc.
Dr. Sohn to Oversee Development of Next Gen COVID-19 Vaccine to Treat Kidney Failure Patients, Late-Stage Rabies Therapeutic and Age-related Macular Degeneration Boca Raton, FL, Oct. 12, 2021 ...
eWellness Announces that it will Develop & Launch a Digital Occupational Therapy Platform by the end of 2019
20 mai 2019 09h00 HE
|
eWellness Healthcare Corp
Culver City, CA, May 20, 2019 (GLOBE NEWSWIRE) -- eWellness Healthcare Corporation – (OTCQB: EWLL) – is the first physical therapy telehealth company to offer insurance reimbursable real-time...